Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 292
Selected: 0
NCT IDTitle
NCT02246244Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress
NCT00180882LMBA02 Protocol for Patients With a Burkitt Lymphoma
NCT03010553Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot
NCT01786031Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program
NCT03604588Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers
NCT03010124Prognostic and Predictive Biomarkers in Ovarian Cancers
NCT06840782First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.
NCT05947903Validation of the European Oncology Quality of Life Toolkit
NCT00180999Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course
NCT01566019Molecular Screening for Cancer Treatment Optimization
NCT01864850Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC
NCT04567446Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach
NCT00180921Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck
NCT00418327Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
NCT00126256Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer
NCT07001618Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
NCT00811759Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
NCT02233049Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
NCT04477681Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
NCT04953312Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)
NCT02666690Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast
NCT05889585Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated with High-dose Chemotherapy and Autologous Stem Cell Transplant
NCT00127088Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
NCT03402568Alcohol Consumption and Circulating Metabolites
NCT03614936Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck
NCT01887340Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
NCT04826432Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis
NCT04270864Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers
NCT02679963Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer
NCT05476939Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
NCT01180335Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer
NCT05821790Role of the Tumor Microenvironment in Aggressive Meningiomas
NCT00634777Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma
NCT01226394Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients
NCT00162708Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
NCT06160596Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
NCT00181168Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
NCT04221035High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT00407433Clinical Studies of Gemcitabine-Oxaliplatin
NCT02857569A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma
NCT00162656Treatment of Mature B-cell Lymphoma/Leukaemia
NCT06505590STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related Fatigue
NCT07471425Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor
NCT00002858Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer
NCT07544225Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
NCT00006455Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99)
NCT05705687Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors
NCT00359645Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
NCT03819101Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
NCT00162812Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin